Abeona Therapeutics (ABEO) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Abeona Therapeutics (ABEO) over the last 15 years, with Q3 2025 value amounting to -$207.5 million.
- Abeona Therapeutics' Enterprise Value fell 8852.86% to -$207.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$207.5 million, marking a year-over-year decrease of 8852.86%. This contributed to the annual value of -$98.1 million for FY2024, which is 8654.97% down from last year.
- Latest data reveals that Abeona Therapeutics reported Enterprise Value of -$207.5 million as of Q3 2025, which was down 8852.86% from -$225.9 million recorded in Q2 2025.
- In the past 5 years, Abeona Therapeutics' Enterprise Value registered a high of -$23.5 million during Q3 2022, and its lowest value of -$225.9 million during Q2 2025.
- Moreover, its 5-year median value for Enterprise Value was -$62.7 million (2024), whereas its average is -$83.6 million.
- As far as peak fluctuations go, Abeona Therapeutics' Enterprise Value surged by 6690.99% in 2022, and later tumbled by 23157.1% in 2024.
- Over the past 5 years, Abeona Therapeutics' Enterprise Value (Quarter) stood at -$50.9 million in 2021, then dropped by 3.09% to -$52.5 million in 2022, then decreased by 0.15% to -$52.6 million in 2023, then tumbled by 86.55% to -$98.1 million in 2024, then crashed by 111.56% to -$207.5 million in 2025.
- Its Enterprise Value stands at -$207.5 million for Q3 2025, versus -$225.9 million for Q2 2025 and -$152.7 million for Q1 2025.